doi: 10.7501/j.issn.0253-2670.2025.07.014
Objective To investigate the effect and mechanism of morroniside on ameliorating kidney injury in fructose-fed mice. Methods A total of 48 male C57BL/6 mice were randomly divided into control group, model group, allopurinol (25 mg/kg) group, morroniside low-dose (25 mg/kg) group, morroniside high-dose (50 mg/kg) group and morroniside (50 mg/kg) + glutathione peroxidase 4 (GPX4) inhibitor RSL3 (5 mg/kg) group. The mice in control group were given normal drinking water, and mice in the other groups were fed with 30% fructose water, while the mice in each treatment group were given corresponding drugs once a day for eight consecutive weeks. At the end of the experiment, serum, urine and kidney samples were collected from each group of mice, and body weight and kidney weight were recorded, the kidney index was calculated; The contents of creatinine (Cre), blood urea nitrogen (BUN) and uric acid (UA) in serum as well as the content of urinary protein in urine were detected, respectively. Meanwhile, the levels of reactive oxygen species (ROS), malondialdehyde (MDA), total-superoxide dismutase (T-SOD), lipid hydroperoxide (LPO), total iron, and ferrous ion (Fe2+) in kidney of mice in each group were detected. Histopathological changes in liver was observed by hematoxylin-eosin (HE) staining, Masson staining and Prussian Blue staining. qRT-PCR was used to detect the mRNA expressions of GPX4 and solute carrier family 7 member 11 (SLC7A11) in kidney tissue of mice in each group. Western blotting and immunohistochemistry were used to detect the protein expression levels of GPX4 and SLC7A11 in kidney tissue of mice in each group. Results Compared with control group, mice in model group showed significantly increased body weight, kidney weight and kidney index (P < 0.01), significantly increased contents of Cre, BUN, UA in serum and urinary protein (P < 0.01), significantly increased levels of ROS, MDA, LPO, total iron and Fe2+ in kidney tissues (P < 0.01), significantly decreased T-SOD activity (P < 0.01), and significantly reduced mRNA and protein expression levels of GPX4 and SLC7A11 in kidney tissues (P < 0.01). Meanwhile, the kidney of mice in model group showed kidney tubular dilatation, glomerular fibrosis and iron deposition. Compared with model group, morroniside significantly decreased body weight, kidney weight and kidney index (P < 0.05, 0.01), significantly decreased levels of Cre, BUN, UA in serum as well as the content of urinary protein in urine (P < 0.05, 0.01), significantly decreased the contents of ROS, MDA, LPO, total iron, and Fe2+ in kidney tissues (P < 0.05, 0.01), and significantly increased T-SOD activity in kidney tissues (P < 0.01). Meanwhile, morroniside was able to attenuate renal tubular dilatation, glomerular fibrosis and iron deposition, and significantly increased the mRNA and protein expression levels of GPX4 and SLC7A11 in kidney tissues (P < 0.05, 0.01). Intervention with GPX4 inhibitor (RSL3) could significantly reverse the effect of morroniside on inhibiting ferroptosis by activating GPX4/SLC7A11 signaling pathway to improve renal dysfunction and kidney injury in fructose-fed mice. Conclusion Morroniside can ameliorate kidney injury in fructose-diet mice by modulating GPX4-mediated ferroptosis.